| Literature DB >> 33364611 |
Luciano Andrés Rossi1, Tomas Gorodischer1, Rodrigo Brandariz1, Ignacio Tanoira1, Ignacio Pasqualini1, Maximiliano Ranalletta1.
Abstract
PURPOSE: To analyze return to sports, functional outcomes, and complications following the Latarjet procedure in competitive athletes with anterior glenohumeral instability and glenoid bone loss <20%.Entities:
Year: 2020 PMID: 33364611 PMCID: PMC7754520 DOI: 10.1016/j.asmr.2020.06.004
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Patients Demographics
| Variable | |
|---|---|
| Sex, men/women, n | 62/3 |
| Side, right, n (%) | 39 (60%) |
| Dominant involvement, n (%) | 29 (45%) |
| Age at the time of surgery, y, mean (range) | 23.9 (16-31) |
| Type of surgery | |
| Primary, n (%) | 29 (45%) |
| Revision, n (%) | 36 (55%) |
| Glenoid bone loss, % (range) | 12% (0-18) |
| On-track/off-track lesions | |
| On track, n (%) | 40 (62%) |
| Off-track, n (%) | 25 (38%) |
| Follow-up, mo (range) | 53 (36-96) |
| Type of sport, | |
| G1 | 12 (18%) |
| G2 | 35 (54%) |
| G3 | 9 (14%) |
| G4 | 9 (14%) |
According to Di Giacomo et al.
According to Allain et al.
Summary of Functional Outcomes and Return to Sport
| Variable | Preoperative | Postoperative | |
|---|---|---|---|
| Rowe score | 51 ± 15 | 95 ± 7.5 | <.01 |
| ASOSS | 29 ± 7.9 | 92 ± 15 | <.01 |
| Forward flexion | 173 ± 6.1 | 171 ± 6.2 | .20 |
| ER in adduction | 67 ± 2.8 | 66 ± 3.6 | .99 |
| Return to sport, n (%) | – | 61/65 (94%) | – |
| Return to same level | – | 51/61 (84%) | – |
NOTE. Values are expressed as mean ± SD unless otherwise indicated. paired rank test.
ASOSS, Athletic Shoulder Outcome Scoring System; ER, external rotation.
Comparative Outcomes Between Primary and Revision Procedures
| Primary Procedures (n = 29) | Revision Procedures (n = 36) | |||||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Delta | Pre | Post | Delta | |||
| Rowe | 50.5 ± 2 | 95.9 ± 6 | –45.3 ± 13 | <.001 | 51.8 ± 17 | 93.7 ± 8 | –41.9 ± 19 | <.001 |
| ASOSS | 28.1 ± 18 | 89.7 ± 18 | –61.6 ± 20 | <.001 | 29.1 ± 8 | 94.0 ± 11 | –64.9 ± 13 | <.001 |
| Forward flexion | 170.76 ± 6 | 171.5 ± 6 | –0.76 ± 5 | .467 | 169.9 ± 6 | 170.3 ± 6 | –0.39 ± 5 | .667 |
| ER in adduction | 65.8 ± 4 | 65.6 ± 4 | 0.17 ± 4 | .83 | 67.1 ± 1 | 67.1 ± 2 | 0.05 ± 2 | .878 |
| Return to sport, n (%) | 26/29 (90%) | 35/36 (97%) | .207 | |||||
| Return to same level | 21/26 (80%) | 30/35 (86%) | .395 | |||||
ASOSS, Athletic Shoulder Outcome Scoring System; ER, external rotation; pre, preoperative; post, postoperative.
Comparative Outcomes Between Patients Operated With the Classic and the Congruent-Arc Procedures
| Classic Latarjet (n = 26) | Congruent-Arc Latarjet (n = 39) | |||||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Delta | Pre | Post | Delta | |||
| Rowe | 50.3 ± 15 | 94.8 ± 7 | –44.5 ± –17 | <.001 | 52 ± 15 | 94.6 ± 7 | –42.5 ± 16 | <.001 |
| ASOSS | 29.6 ± 9 | 95.0 ± 9 | –65.4 ± 14 | <.001 | 27.8 ± 6 | 89.6 ± 18 | –61.7 ± 18 | <.001 |
| Forward flexion | 170.6 ± 5 | 170 ± 6 | 0.66 ± 6 | .55 | 169.9 ± 6 | 171.5 ± 6 | –1.6 ± 4 | .05 |
| ER in adduction | 66.6 ± 2 | 66.6 ± 3 | –0.03 ± 2 | .9 | 66.5 ± 3 | 66.3 ± 3 | 35.22 ± 3 | .73 |
| Return to sport, n (%) | 28/30 (93%) | 33/35 (94%) | .87 | |||||
| Return to same level | 23/30 (77%) | 28/35 (80%) | .74 | |||||
ASOSS, Athletic Shoulder Outcome Scoring System; ER, external rotation; pre, preoperative; post, postoperative.
Results of Functional Scores by Type of Sports
| Rowe | ASOSS | ||
|---|---|---|---|
| G1 | 12 (18%) | 95 ± 5 | 90 ± 22 |
| G2 | 35 (54%) | 94 ± 8 | 92 ± 16 |
| G3 | 9 (14%) | 97 ± 7 | 97 ± 4 |
| G4 | 9 (14%) | 96 ± 9 | 91 ± 2 |
| .55 | .04 |
ASOSS, Athletic Shoulder Outcome Scoring System.
Summary of Complications and Their Treatment
| Complications | Frequency | Management |
|---|---|---|
| Graft nonunion | 3/65 (4.5%) | The 3 patients were asymptomatic so they were managed conservatively |
| Recurrence | 2/65 (3%) | |
| Dislocations | 1/65 (1.5%) | Revised with autologous iliac bone graft |
| Subluxations | 1/65 (1.5%) | Conservative treatment |
| Superficial wound infection | 1/65 (1.5%) | Oral antibiotics, 2 weeks |
| Musculocutaneous Neuropraxia | 1/65 (1.5%) | Full recovery with conservative treatment |